Sign Up Now to Download a Free Research Report on

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts




Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

BioLineRx Ltd.

Bioline RX shares hit a high of $2.00 a share Wednesday before settling to close at $1.88, an increase of 3.30 percent. The company has reported positive results from a Phase IIa trial of BL-7040 for the treatment of ulcerative colitis, a form of inflammatory bowel disease.

Going forward ... (see research report)



RESEARCH REPORT ON Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on